Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Pleven – page 7

300 clinical trials in Pleven, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pleven at a glance
300
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

300 trials in Pleven

Open in trial search

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Study on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Riliprubart
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Ascentage Pharma Group Inc.

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Seizure

Recruiting

Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Alprazolam
  • Sponsor:UCB Biopharma

Study on the Effects of IMU-838 (Vidofludimus Calcium) for Patients with Relapsing-Remitting Multiple Sclerosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Vidofludimus Calcium
  • Sponsor:Immunic AG

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Vidofludimus Calcium
  • Sponsor:Immunic AG

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Psychotic disorder+1

Recruiting

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Pleven

What the registry says about research in the country

01 Respiratory Health

Innovative research focusing on viral respiratory infections, including studies of vaccines against RSV, human metapneumovirus, and influenza in older adults. Clinical trials aim to enhance protection against severe respiratory diseases.

  • RSV and hMPV Prevention
  • Influenza Vaccine Development
  • Viral Lung Infection Treatment

Emphasis on vaccine efficacy and immune response in vulnerable populations.

02 Dermatological Conditions

Comprehensive studies addressing various skin conditions, with particular focus on psoriasis and hidradenitis suppurativa. Research includes both systemic and targeted therapies.

  • Plaque Psoriasis Management
  • Hidradenitis Suppurativa Treatment
  • Genital Psoriasis Therapy

Innovative approaches in chronic skin condition management.

03 Cardiovascular Research

Advanced studies in cardiovascular disease prevention and treatment, including investigations into heart failure prevention and lipid management strategies.

  • Heart Failure Prevention
  • Lipoprotein Management
  • Cardiovascular Risk Reduction

Focus on preventive strategies and innovative therapeutic approaches.

04 Autoimmune Disorders

Investigations into various autoimmune conditions, including multiple sclerosis and Sjögren's disease, exploring new therapeutic options and treatment approaches.

  • Multiple Sclerosis Treatment
  • Sjögren's Disease Management
  • Inflammatory Disease Therapy

Emphasis on improving quality of life for patients with chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.